Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Purpura, Thrombotic Thrombocytopenic | 5 | 2014 | 11 | 0.940 |
Why?
|
| Platelet Activating Factor | 4 | 2007 | 14 | 0.870 |
Why?
|
| ADAM Proteins | 3 | 2012 | 13 | 0.830 |
Why?
|
| Apolipoprotein A-I | 5 | 2012 | 68 | 0.680 |
Why?
|
| Plasma Exchange | 1 | 2014 | 10 | 0.490 |
Why?
|
| Oxymorphone | 1 | 2014 | 9 | 0.490 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2014 | 8 | 0.490 |
Why?
|
| Mass Spectrometry | 3 | 2006 | 99 | 0.380 |
Why?
|
| Neutrophils | 4 | 2007 | 102 | 0.380 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 2008 | 1 | 0.340 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 6 | 0.330 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 3 | 0.330 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2007 | 93 | 0.330 |
Why?
|
| Heart Diseases | 1 | 2008 | 97 | 0.320 |
Why?
|
| Myocardium | 1 | 2008 | 170 | 0.310 |
Why?
|
| Myocardial Infarction | 2 | 2008 | 412 | 0.300 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2006 | 2 | 0.300 |
Why?
|
| Blood Coagulation Disorders | 1 | 2006 | 9 | 0.300 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 40 | 0.290 |
Why?
|
| Hematoma | 1 | 2006 | 23 | 0.290 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 15 | 0.290 |
Why?
|
| Clinical Chemistry Tests | 1 | 2004 | 1 | 0.260 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2004 | 6 | 0.260 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 14 | 0.250 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 11 | 0.250 |
Why?
|
| Humans | 21 | 2014 | 28998 | 0.250 |
Why?
|
| Thrombosis | 1 | 2004 | 60 | 0.240 |
Why?
|
| Recombinant Proteins | 4 | 2008 | 248 | 0.230 |
Why?
|
| Cholesterol | 4 | 2012 | 229 | 0.210 |
Why?
|
| Membrane Microdomains | 2 | 2012 | 24 | 0.200 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2012 | 60 | 0.200 |
Why?
|
| Autoimmunity | 2 | 2010 | 26 | 0.180 |
Why?
|
| Lipoproteins, HDL | 2 | 2012 | 247 | 0.180 |
Why?
|
| Male | 9 | 2014 | 17767 | 0.160 |
Why?
|
| Female | 9 | 2014 | 18112 | 0.150 |
Why?
|
| Mixed Function Oxygenases | 2 | 2008 | 12 | 0.150 |
Why?
|
| Diet, Atherogenic | 3 | 2011 | 61 | 0.140 |
Why?
|
| Obesity | 1 | 2003 | 1062 | 0.140 |
Why?
|
| Middle Aged | 6 | 2014 | 10805 | 0.140 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 114 | 0.130 |
Why?
|
| Atherosclerosis | 2 | 2011 | 691 | 0.120 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2014 | 27 | 0.120 |
Why?
|
| Adult | 4 | 2014 | 8391 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 531 | 0.110 |
Why?
|
| Plasmapheresis | 1 | 2012 | 9 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 493 | 0.110 |
Why?
|
| Macrophages | 2 | 2010 | 188 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 2012 | 67 | 0.100 |
Why?
|
| Immunosuppression | 1 | 2012 | 80 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2011 | 48 | 0.100 |
Why?
|
| Recurrence | 1 | 2012 | 235 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 50 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 167 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 16 | 0.100 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 22 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 33 | 0.090 |
Why?
|
| Plasmids | 2 | 2008 | 48 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2011 | 711 | 0.090 |
Why?
|
| Methods | 1 | 2008 | 7 | 0.080 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2008 | 4 | 0.080 |
Why?
|
| von Willebrand Factor | 1 | 2008 | 17 | 0.080 |
Why?
|
| Necrosis | 1 | 2008 | 52 | 0.080 |
Why?
|
| Troponin I | 1 | 2008 | 17 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2008 | 50 | 0.080 |
Why?
|
| Automation | 1 | 2008 | 30 | 0.080 |
Why?
|
| Aortic Diseases | 1 | 2009 | 54 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 21 | 0.080 |
Why?
|
| Risk Factors | 2 | 2008 | 3509 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2008 | 3100 | 0.080 |
Why?
|
| Factor VII | 1 | 2008 | 5 | 0.080 |
Why?
|
| Protein Engineering | 1 | 2008 | 17 | 0.080 |
Why?
|
| Acetyltransferases | 2 | 2005 | 2 | 0.080 |
Why?
|
| Lipids | 2 | 2010 | 208 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 45 | 0.080 |
Why?
|
| Echocardiography | 1 | 2008 | 140 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2005 | 36 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2005 | 126 | 0.080 |
Why?
|
| Copper | 1 | 2007 | 11 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2007 | 22 | 0.080 |
Why?
|
| Young Adult | 1 | 2014 | 2398 | 0.080 |
Why?
|
| Deuterium | 1 | 2007 | 9 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2005 | 225 | 0.080 |
Why?
|
| Indicators and Reagents | 1 | 2007 | 15 | 0.070 |
Why?
|
| Isotope Labeling | 1 | 2007 | 17 | 0.070 |
Why?
|
| Calibration | 1 | 2007 | 25 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 34 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 26 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 162 | 0.070 |
Why?
|
| Antifibrinolytic Agents | 1 | 2006 | 16 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 8 | 0.070 |
Why?
|
| DNA Primers | 1 | 2006 | 87 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 60 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3094 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2006 | 82 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2006 | 84 | 0.070 |
Why?
|
| Mice | 5 | 2011 | 2368 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 724 | 0.070 |
Why?
|
| Base Sequence | 1 | 2006 | 240 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 280 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 37 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 350 | 0.070 |
Why?
|
| Vitamin K | 1 | 2005 | 9 | 0.070 |
Why?
|
| Factor IX | 1 | 2005 | 8 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2003 | 446 | 0.070 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 10 | 0.070 |
Why?
|
| Osmotic Pressure | 1 | 2005 | 9 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 66 | 0.060 |
Why?
|
| Glycerophospholipids | 1 | 2004 | 1 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2005 | 42 | 0.060 |
Why?
|
| Chromatography | 1 | 2004 | 4 | 0.060 |
Why?
|
| Lysophosphatidylcholines | 1 | 2004 | 3 | 0.060 |
Why?
|
| Thrombocytosis | 1 | 2004 | 1 | 0.060 |
Why?
|
| Thrombophilia | 1 | 2004 | 6 | 0.060 |
Why?
|
| Pyridines | 1 | 2005 | 78 | 0.060 |
Why?
|
| Catalysis | 1 | 2004 | 64 | 0.060 |
Why?
|
| Phenotype | 1 | 2006 | 629 | 0.060 |
Why?
|
| Imidazoles | 1 | 2005 | 104 | 0.060 |
Why?
|
| Animals | 7 | 2011 | 7296 | 0.060 |
Why?
|
| Factor VIII | 1 | 2004 | 19 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 100 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2004 | 281 | 0.060 |
Why?
|
| Time Factors | 2 | 2009 | 1997 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2005 | 223 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2003 | 272 | 0.060 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2002 | 2 | 0.060 |
Why?
|
| Receptors, Eicosanoid | 1 | 2002 | 3 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 57 | 0.060 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2002 | 44 | 0.060 |
Why?
|
| Factor V | 1 | 2002 | 6 | 0.050 |
Why?
|
| Continental Population Groups | 1 | 2003 | 221 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2002 | 30 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 48 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2002 | 86 | 0.050 |
Why?
|
| Sex Factors | 1 | 2003 | 626 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2002 | 197 | 0.050 |
Why?
|
| Lipoproteins, LDL | 2 | 2011 | 77 | 0.050 |
Why?
|
| Aged | 3 | 2008 | 9461 | 0.050 |
Why?
|
| Aorta | 2 | 2011 | 103 | 0.050 |
Why?
|
| Receptors, LDL | 2 | 2010 | 64 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2010 | 80 | 0.040 |
Why?
|
| Stroke | 1 | 2004 | 522 | 0.040 |
Why?
|
| Lymphocyte Count | 2 | 2010 | 23 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2010 | 92 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 441 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2010 | 573 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 249 | 0.040 |
Why?
|
| Cell Line | 2 | 2008 | 449 | 0.030 |
Why?
|
| Ceramides | 1 | 2012 | 9 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2012 | 7 | 0.030 |
Why?
|
| Biological Transport | 1 | 2012 | 62 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2012 | 85 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2012 | 92 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 36 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 97 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 33 | 0.020 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Triglycerides | 1 | 2011 | 214 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 81 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 74 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2010 | 64 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 41 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 75 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 171 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 332 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2010 | 61 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 107 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 164 | 0.020 |
Why?
|
| Apolipoproteins | 1 | 2011 | 196 | 0.020 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2009 | 2 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 799 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2009 | 41 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 82 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 203 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 127 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 74 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 425 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 76 | 0.020 |
Why?
|
| DNA | 1 | 2009 | 204 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 83 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2007 | 42 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 192 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 503 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 666 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2005 | 15 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 35 | 0.020 |
Why?
|
| Cricetinae | 1 | 2005 | 58 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 42 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 980 | 0.020 |
Why?
|
| Kidney | 1 | 2008 | 485 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 1604 | 0.010 |
Why?
|
| Benzoquinones | 1 | 2002 | 5 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2002 | 12 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 2002 | 16 | 0.010 |
Why?
|
| Calcimycin | 1 | 2002 | 7 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2002 | 5 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2002 | 16 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 37 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 44 | 0.010 |
Why?
|
| Phospholipases A | 1 | 2002 | 28 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 24 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 158 | 0.010 |
Why?
|
| Indoles | 1 | 2002 | 58 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 69 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 3 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 90 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 15 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 24 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 92 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 71 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2002 | 89 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 97 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 289 | 0.010 |
Why?
|
| Synapses | 1 | 2002 | 85 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 735 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 241 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 462 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 855 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 481 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 466 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 436 | 0.010 |
Why?
|